References
- Alibhai SMH, Naglie G, Nam R, et al (2003). Do older men benefit from curative therapy of localized prostate cancer? J Clin Oncol, 21, 3318-27. https://doi.org/10.1200/JCO.2003.09.034
- Andriole GL, Crawford ED, Grubb RL, et al (2009). Mortality results from a randomized prostate-cancer screening trial. N Engl J Med, 360, 1310-9. https://doi.org/10.1056/NEJMoa0810696
- Barry M (2006). The PSA conundrum. Arch Intern Med, 166, 7-8. https://doi.org/10.1001/archinte.166.1.7
- Bokhorst LP, Bangma CH, van Leenders GJ, et al (2013). Prostate-specific antigen-based prostate cancer screening: reduction of prostate cancer mortality after correction for nonattendance and contamination in the rotterdam section of the European randomized study of screening for prostate cancer. Eur Urol, [Epub ahead of print].
- Carter HB (2006). Assessing risk: does this patient have prostate cancer? J Natl Cancer Inst, 98, 506-7. https://doi.org/10.1093/jnci/djj155
- Dale W, Bilir P, Han M, et al (2005). The role of anxiety in prostate carcinoma. Cancer. 104, 467-78. https://doi.org/10.1002/cncr.21198
- Eastham JA, May R, Robertson JL, et al (1999). Development of a nomogram that predicts the probability of a positive prostate biopsy in men with an abnormal digital rectal examination and a prostate-specific antigen between 0 and 4 ng/mL. Urology, 54, 709-13. https://doi.org/10.1016/S0090-4295(99)00213-7
- Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917. https://doi.org/10.1002/ijc.25516
- Froehner M, Koch R, Wirth MP (2013). Comorbidity and survival of patients selected for radical prostatectomy at an age of 75 years or older. Asian J Androl, [Epub ahead of print].
- Garzotto M, Hudson RG, Peters L, et al (2003). Predictive modeling for the presence of prostate carcinoma using clinical, laboratory, and ultrasound parameters in patients with prostate specific antigen levels < or =10 ng/mL. Cancer, 98, 1417-22. https://doi.org/10.1002/cncr.11668
- Haas GP, Delongchamps NB, Jones RF, et al (2007). Needle biopsies on autopsy prostates; sensitivity of cancer detection based on true prevalence. J Natl Cancer Inst, 99, 1484-9. https://doi.org/10.1093/jnci/djm153
- Heidenreich A, Bellmunt J, Bolla M, et al (2011). EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localized disease. Eur Urol, 59, 61-71. https://doi.org/10.1016/j.eururo.2010.10.039
- Jemal A, Siegel R, Xu J, et al (2010). Cancer statistics. CA Cancer J Clin, 60, 277-300. https://doi.org/10.3322/caac.20073
- Lumen N, Fonteyne V, De Meerleert G, et al (2012). Population screening for prostate cancer: an overview of available studies and meta-analysis. Int J Urol, 19, 100-8. https://doi.org/10.1111/j.1442-2042.2011.02912.x
- Nomikos M, Mariappan P, Zachou A, et al (2010). Could prostate biopsies be avoided in men older than 75 years with raised PSA? Urol Int, 85, 410-4. https://doi.org/10.1159/000320378
- Ojewola RW, Tijani KH, Jeje EA, (2013). An evaluation of usefulness of prostate specific antigen and digital rectal examination in the diagnosis of prostate cancer in an unscreened population: experience in a Nigerian teaching hospital. West Afr J Med, 32, 8-13.
- Parker C, Muston D, Melia J, et al (2006). A model of the natural history of screen-detected prostate cancer, and the affect of radical treatment on overall survival. Br J Cancer, 94, 1361-8. https://doi.org/10.1038/sj.bjc.6603105
- Polat K, Tuzel E, Aktepe F, et al (2009). Investigation of the incidence of latent prostate cancer and high-grade prostatic intraepithelial neoplasia in an autopsy series of Turkish males. Turkish J Urol, 35, 96-100.
- Roobol MJ, Zappa M, Maattanen L, et al (2007). The value of different screening tests in predicting prostate biopsy outcome in screening for prostate cancer data from a multicenter study (ERSPC). Prostate, 67, 439-46. https://doi.org/10.1002/pros.20545
- Scattoni V, Sangalli M, Roscigno M, et al (2005). Detection and diagnosis of prostate cancer: what's new. Arch Ital Urol Androl, 77, 173-9.
- Schroder FH, Hugosson J, Roobol MJ, et al (2009). Screening and prostate-cancer mortality in a randomized European study. N Engl J Med, 360, 1320-8. https://doi.org/10.1056/NEJMoa0810084
- Shigemura K, Arakawa S, Yamanaka K, et al (2008). Potential predictive factors of positive prostate biopsy in the Japanese population. Int Urol Nephrol, 40, 91-6. https://doi.org/10.1007/s11255-007-9219-5
- Situmorang GR, Umbas R, Mochtar CA, et al (2012). differently? Asian Pac J Cancer Prev, 13, 4577-80. https://doi.org/10.7314/APJCP.2012.13.9.4577
- Taichman RS, Loberg RD, Mehra R, et al (2007).The evolving biology and treatment of prostate cancer. J Clin Invest, 117, 2351-61. https://doi.org/10.1172/JCI31791
- Tuncer M (2007). Cancer control in Turkey. Turkish Ministry of Health Ankara, 1, 37-40.
- US Preventive Services Task Force (2008). Screening for prostate cancer: US preventive services task force recommendation statement. Ann Intern Med, 149, 185-91. https://doi.org/10.7326/0003-4819-149-3-200808050-00008
- Welch HG, Black WC (2010). Overdiagnosis in cancer. J Natl Cancer Inst, 102, 605-13. https://doi.org/10.1093/jnci/djq099
- Wolf AM, Wender RC, Etzioni RB, et al (2010). American Cancer Society guideline for the early detection of prostate cancer: update 2010. CA Cancer J Clin, 60, 70-98. https://doi.org/10.3322/caac.20066
Cited by
- Cumulative Probability of Prostate Cancer Detection Using the International Prostate Symptom Score in a Prostate-specific Antigen-based Population Screening Program in Japan vol.15, pp.17, 2014, https://doi.org/10.7314/APJCP.2014.15.17.7079
- Prostate Biopsy in the Elderly: Histologic Findings and Treatment Necessity vol.15, pp.20, 2014, https://doi.org/10.7314/APJCP.2014.15.20.8937
- Utility of Digital Rectal Examination, Serum Prostate Specific Antigen, and Transrectal Ultrasound in the Detection of Prostate Cancer: A Developing Country Perspective vol.15, pp.7, 2014, https://doi.org/10.7314/APJCP.2014.15.7.3087
- Comparative Histopathological Characterization of Prostate Cancer in Saudi Patients by Conventional and 2005 ISUP Modified Gleason Systems vol.15, pp.24, 2014, https://doi.org/10.7314/APJCP.2014.15.24.10923
- Frequency of Unnecessarily Biopsies among Patients with Suspicion of Prostate Cancer in Syrian Men vol.16, pp.14, 2015, https://doi.org/10.7314/APJCP.2015.16.14.5967
- Prostate Cancer Screening in the Fit Chilean Elderly: a Head to Head Comparison of Total Serum PSA versus Age Adjusted PSA versus Primary Circulating Prostate Cells to Detect Prostate Cancer at Initial Biopsy vol.16, pp.2, 2015, https://doi.org/10.7314/APJCP.2015.16.2.601
- Does an asymmetric lobe in digital rectal examination include any risk for prostate cancer? results of 1495 biopsies vol.42, pp.4, 2016, https://doi.org/10.1590/S1677-5538.IBJU.2014.0598